Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,656 across all filing types
Latest filing 2018-06-19 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
关于聘任高级管理人员、内审内控部负责人和证券事务代表的公告
Board/Management Information Classification · 100% confidence The document is an announcement from Shenzhen BGI Genomics Co., Ltd. regarding the appointment of senior management personnel, the head of internal audit and control, and securities affairs representatives. It includes detailed resumes and qualifications of the appointed individuals. The content focuses on changes in the company's board of directors and senior management positions, with no financial statements or report data included. The document length is 4401 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Board/Management Information (MANG).
2018-06-19 Chinese
关于董事会、监事会和高级管理人员换届完成的公告
Board/Management Information Classification · 100% confidence The document is an announcement from Shenzhen BGI Co., Ltd. regarding the completion of the re-election and appointment of the company's board of directors, supervisory board, and senior management personnel. It details the changes in board members, supervisory members, and senior executives, including names and roles. There is no financial data, no report or presentation attached, and the document focuses solely on management and board changes. This fits the definition of 'Board/Management Information' (MANG). The document length is short and it is not a report or certification but a formal announcement of management changes.
2018-06-19 Chinese
关于召开2018年第二次临时股东大会的提示性公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2018 second extraordinary general meeting of shareholders for Shenzhen BGI Genomics Co., Ltd. It includes information about the meeting date, voting procedures (including cumulative voting for board and supervisory committee elections), agenda items related to board member adjustments and elections, and instructions for shareholder registration and proxy voting. The content focuses on governance matters such as board member elections and amendments to the company's articles and independent director system. There is no financial data or earnings information, nor is it a transcript or presentation. The document is not a report publication announcement but a formal notice and detailed information about the shareholder meeting and related governance proposals. Therefore, it fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management and related meeting notices.
2018-06-14 Chinese
关于全资子公司获得中国合格评定国家认可委员会实验室认可证书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Shenzhen BGI Genomics Co., Ltd. regarding its wholly-owned subsidiary receiving a laboratory accreditation certificate from the China National Accreditation Service (CNAS). The content focuses on the certification details, its significance, and a risk disclaimer. There are no financial statements, management discussions, or detailed financial data. The document is short (984 characters) and serves as an official announcement of a certification event rather than a financial or regulatory report. It does not fit into categories like Annual Report, Interim Report, or Regulatory Filings related to financial disclosures. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2018-06-11 Chinese
关于全资子公司通过ISO13485：2016体系认证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (770 characters) from Shenzhen BGI Genomics Co., Ltd. about its wholly-owned subsidiary obtaining ISO 13485:2016 quality management system certification. It includes details about the certification body, certificate validity, and the impact on the company. There are no financial statements, no detailed financial data, no earnings or management discussion, and no mention of a report being attached or published. The document is an official announcement regarding a certification achievement, which does not fit into financial reports or management reports categories. It is not a regulatory filing in the sense of compliance or officer certification, but rather a general regulatory announcement about certification status. Given the content and length, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2018-06-05 Chinese
独立董事候选人声明（蒋昌建）
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate of Shenzhen BGI Genomics Co., Ltd. It contains detailed statements about the candidate's qualifications, compliance with laws and regulations, and independence criteria. There are no financial statements, earnings data, or management discussion of financial results. The content is focused on the candidate's eligibility and compliance for a board position, which aligns with announcements related to board or management changes. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is 5321 characters, which is sufficient for a detailed declaration rather than a brief announcement or certification.
2018-06-01 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.